Search research articles
Contact Us
Filters
Showing results (251-260 of 260) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 260 results.
Toxicology and Applied Pharmacology
|
June 22, 2005
Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan
Chien-Jen Chen, Lin-I Hsu, Chih-Hao Wang, et al.
Emerging Infectious Diseases
|
January 25, 2008
Japanese encephalitis outbreak, Yuncheng, China, 2006
Li-Hua Wang, Shi-Hong Fu, Huan-Yu Wang, et al.
Kidney Diseases (Basel, Switzerland)
|
April 17, 2023
Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study
Wei Chen, Hua-Feng Liu, Qin-Kai Chen, et al.
Journal of Virology
|
June 24, 2011
Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia
Xiao-Ling Pan, Hong Liu, Huan-Yu Wang, et al.
JAMA
|
February 9, 2023
Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial
Hui-Sheng Chen, Yu Cui, Zhong-He Zhou, et al.
Chinese Journal of Integrative Medicine
|
November 24, 2018
Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study
Ying Zheng, Nian-Song Wang, Yu-Ning Liu, et al.
Chinese Medical Journal
|
October 21, 2017
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
Ying Zheng, Guang-Yan Cai, Li-Qun He, et al.
Zhonghua Yi Xue Za Zhi
|
March 23, 2011
[Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China]
Chang-Ming Xiong, Jian-Guo He, Xian-Ling Lu, et al.
Journal of Clinical Pharmacology
|
March 19, 2011
Oral sildenafil therapy for Chinese patients with pulmonary arterial hypertension: a multicenter study
Chang-Ming Xiong, Xian-Ling Lu, Guang-Liang Shan, et al.
Journal of Integrative Medicine
|
February 16, 2021
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial
Jie Wu, Shu-Wei Duan, Hong-Tao Yang, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 260) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 260 results.
Toxicology and Applied Pharmacology
|
June 22, 2005
Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan
Chien-Jen Chen, Lin-I Hsu, Chih-Hao Wang, et al.
Emerging Infectious Diseases
|
January 25, 2008
Japanese encephalitis outbreak, Yuncheng, China, 2006
Li-Hua Wang, Shi-Hong Fu, Huan-Yu Wang, et al.
Kidney Diseases (Basel, Switzerland)
|
April 17, 2023
Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study
Wei Chen, Hua-Feng Liu, Qin-Kai Chen, et al.
Journal of Virology
|
June 24, 2011
Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia
Xiao-Ling Pan, Hong Liu, Huan-Yu Wang, et al.
JAMA
|
February 9, 2023
Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial
Hui-Sheng Chen, Yu Cui, Zhong-He Zhou, et al.
Chinese Journal of Integrative Medicine
|
November 24, 2018
Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study
Ying Zheng, Nian-Song Wang, Yu-Ning Liu, et al.
Chinese Medical Journal
|
October 21, 2017
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
Ying Zheng, Guang-Yan Cai, Li-Qun He, et al.
Zhonghua Yi Xue Za Zhi
|
March 23, 2011
[Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China]
Chang-Ming Xiong, Jian-Guo He, Xian-Ling Lu, et al.
Journal of Clinical Pharmacology
|
March 19, 2011
Oral sildenafil therapy for Chinese patients with pulmonary arterial hypertension: a multicenter study
Chang-Ming Xiong, Xian-Ling Lu, Guang-Liang Shan, et al.
Journal of Integrative Medicine
|
February 16, 2021
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial
Jie Wu, Shu-Wei Duan, Hong-Tao Yang, et al.
Page
of 26